Weekly Roundup: October 19-23

October 23, 2020

ICYMI, some of the content featured this week includes a new episode of our podcast focusing on telemedicine use in dermatology, female representation within the dermatological surgery space, pulsed dye laser and botulinumtoxinA as a combination treatment for rosacea, plus more.

Nano-pulse stimulation shows positive results
The Cutaneous Connection- Episode 9: Telemedicine Use in Dermatology
PDL, botulinumtoxinA improves rosacea symptoms
Women surgeons and Mohs micrographic surgery in the U.S.

Trial compares NMSC destructive techniques

October 21, 2020

A recent study showed that curettage and cryotherapy, and electrodesiccation and curettage are two techniques that have comparable cure rates. The study’s findings highlight the efficacy and reliability of these treatment approaches for minimally invasive cutaneous carcinomas.

Dupilumab provides option for severe AD in younger children

October 21, 2020

In a recent phase 3 trial, dupilumab (Dupixent, Sanofi and Regeneron) demonstrated positive results in itch reduction, skin clearance and quality-of-life. Indicating the biologic as a viable treatment option for severe atopic dermatitis in younger children.

The Mainstream Patient: October 20

October 20, 2020

This week’s edition of The Mainstream Patient features stories about postpartum hair loss, vitamin C benefits, witch hazel, fraxel laser treatments, isotretinoin’s effect on both the skin and mind, oily skin myths, plus more.

Negotiating better managed care contracts

October 20, 2020

Jerri Ivey, director of revenue cycle management at VitalSkin Dermatology, shares steps you can take and ways you can educate yourself in order to negotiate better managed care contracts.